HIV Prevention & Post-Exposure Care
Protecting Your Health with Modern HIV Prevention
Today, HIV prevention is more effective than ever. Whether you want to proactively reduce your risk or need urgent treatment after a possible exposure, there are evidence-based options that can help.
At The PrEP NP, we provide personalized prevention care designed around your lifestyle, risk profile, and medical needs.
What Is PrEP?
PrEP (Pre-Exposure Prophylaxis) is a preventive HIV medication taken before potential exposure to significantly reduce the risk of acquiring HIV.
When taken as prescribed, PrEP is highly effective and remains one of the most powerful tools available for HIV prevention.
PrEP works by maintaining protective medication levels in your body, helping block HIV from establishing infection if exposure occurs.
Current FDA-Approved PrEP Options
Oral PrEP: Truvada®
Daily oral tablet
Truvada contains:
Emtricitabine (FTC)
Tenofovir disoproxil fumarate (TDF)
Best suited for:
Individuals at risk through receptive vaginal sex
Men who have sex with men
People who inject drugs
Patients seeking a proven daily prevention option
Oral PrEP: Descovy®
Daily oral tablet
Descovy contains:
Emtricitabine (FTC)
Tenofovir alafenamide (TAF)
Descovy may offer:
Lower kidney toxicity risk compared with TDF-based regimens
Lower impact on bone mineral density in appropriate patients
Important note:
Descovy is currently not approved for individuals at risk through receptive vaginal sex.
Injectable PrEP: Apretude®
Long-acting injectable option
Apretude is:
The first FDA-approved injectable PrEP medication
Administered by a healthcare provider
Given monthly for the first 2 doses, then every 2 months thereafter
Best suited for:
Patients who prefer not to take daily medication
Individuals seeking a discreet long-acting prevention strategy
Patients with adherence challenges with oral PrEP
Injectable PrEP YEZTUGO® (Lenacapavir) – Twice-Yearly
Long-Acting HIV Prevention, Simplified
For individuals seeking a highly effective HIV prevention option without the burden of daily pills or frequent injections, YEZTUGO® (lenacapavir) offers a new approach.
YEZTUGO is the first FDA-approved HIV PrEP option designed for dosing just twice per year, making it one of the longest-acting prevention strategies currently available.
This may be an excellent option for individuals who:
Prefer a low-maintenance prevention strategy
Have difficulty remembering daily medication
Want a discreet, long-acting alternative to oral PrEP
Prefer fewer clinic visits compared with other injectable options
What Is PEP?
PEP (Post-Exposure Prophylaxis) is emergency HIV prevention used after a possible exposure.
PEP must be started within 72 hours of potential exposure. The sooner, the better.
Treatment typically lasts 28 days and involves a short course of prescription antiretroviral therapy.
PEP may be appropriate after:
Condom failure
Unprotected sexual exposure
Sexual assault
Needle-sharing exposure
Occupational needle stick injury
Known or suspected HIV exposure
PEP is intended for emergency situations—not ongoing prevention.
If repeated exposures are a concern, PrEP may be the more appropriate long-term strategy.
PrEP vs PEP: What’s the Difference?
PrEP = Prevention before exposure
PrEP is taken proactively to reduce future HIV risk.
PEP = Emergency treatment after exposure
PEP is used after a possible exposure to help prevent infection before HIV can establish itself.
Both are highly effective when used appropriately and under medical supervision.
Need PEP Urgently?
If you believe you may have been exposed to HIV, time matters.
PEP must be started within 72 hours of exposure to be effective.
If you are outside normal business hours or experiencing an urgent exposure, seek immediate medical care at the nearest emergency department or urgent care facility.
Meet @ThePrEPNP

